E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/7/2008 in the Prospect News Emerging Markets Daily.

Croatia's Pliva will ask 5¾% bondholders to OK early redemption

By Angela McDaniels

Tacoma, Wash., April 7 - Pliva dd plans to ask holders of its €75 million 5¾% bonds due 2011 to approve an amendment that would allow the company to call the bonds on April 30.

Upon redemption of the bonds, Pliva would pay 100.5 plus accrued interest, according to a company news release.

The bonds priced at 99.744 in May 2004. Zagrebaeka banka dd is the trustee.

Pliva is based in Zagreb, Croatia, and is the European headquarters for Barr Pharmaceuticals, Inc., a specialty pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.